LOAMS
HAE icon

Lombard Odier Asset Management (Switzerland)’s Haemonetics HAE Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-76,000
Closed -$8.71M – 360
2018
Q3 		$8.71M Buy
76,000
+3,500
+5% +$362K 0.86% 31
2018
Q2 		$6.5M Buy
+72,500
New +$6.12M 0.69% 40
2014
Q4 		– Sell
-64,779
Closed -$2.27M – 521
2014
Q3 		$2.27M Buy
+64,779
New +$2.31M 0.06% 336

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s HAE Position: Q4 2018 in Review

Lombard Odier Asset Management (Switzerland) sold out of Haemonetics (HAE) in Q4 2018, closing a stake of 76,000 shares — an estimated $8.71M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in HAE in Q3 2014 and held it in 3 quarters. The position peaked at $8.71M in Q3 2018. 279 funds tracked by Wall St. Rank hold HAE as of Q4 2018.

  • Lombard Odier Asset Management (Switzerland) reported no remaining Haemonetics position as of Q4 2018 after selling out during the quarter.
  • Lombard Odier Asset Management (Switzerland) sold 76,000 Haemonetics shares in Q4 2018, an estimated $8.71M.
  • Lombard Odier Asset Management (Switzerland) first reported a position in Haemonetics in Q3 2014 and held it in 3 quarters.
  • Lombard Odier Asset Management (Switzerland)'s Haemonetics position peaked at $8.71M in Q3 2018.
  • 279 funds tracked by Wall St. Rank held Haemonetics as of Q4 2018.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q4 2018, filed 14 Feb 2019.